Husseini K. Manji, MD

Considering challenges and opportunities in digital health solutions for mental health care.

How can we face the current pandemic while addressing the brain health crisis?

Brain health disorders cost the global economy more than $3 trillion per year in lost productivity. What can we do about it?

Although several antimanic agents are available to treat individuals with bipolar disorder (BD), many patients have a less than satisfactory response or experience adverse effects.1 With the exception of lithium, all of the current antimanic agents are either anticonvulsant or antipsychotic drugs. It is remarkable that no drug has been developed specifically for BD, especially because this illness was conceptualized more than a century ago.